Sign in
4

Changes in Ownership

Werewolf Therapeutics, Inc. Filed Acc 0000899243-23-016373

Options or other derivatives

  • Director acquired 13,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sherman Michael A. Director 2023-06-21 Grant or award · Stock Option (right to buy) +13,200 13,200 D
Loading xslF345X04/doc4.xml…